Ra­dio­phar­ma star­tups stay hot as Al­pha-9 bags $175M Se­ries C

7 months ago
Financing
Startups

Life sci­ences in­vestor Di­men­sion seeks to raise $500M sec­ond fund

7 months ago
Financing
Startups

Hous­ton start­up March Bio­sciences rais­es $28M to get CAR-T in­to Phase 2

7 months ago
Financing
Startups

UK’s price watch­dog says Lil­ly’s Alzheimer’s drug is too cost­ly for broad up­take

7 months ago
Pharma

Mer­ck pays $30M to buy ‘chameleon’ ap­proach to dead­ly brain can­cers

7 months ago
Deals
R&D

Roche says it is un­de­terred by up­com­ing biosim­i­lar threat to Vabysmo

7 months ago
R&D
Pharma

Cor­rect­ed: Sang­amo to seek ac­cel­er­at­ed ap­proval for Fab­ry gene ther­a­py, claims it won't need con­fir­ma­to­ry study

7 months ago
R&D
Cell/Gene Tx

Eye drop mak­er to merge with a reti­nal gene ther­a­py start­up from Spark co-founder

7 months ago
Startups
Deals

Sen­a­tors ques­tion whether Pfiz­er, Eli Lil­ly tele­health plat­forms vi­o­late law

7 months ago
Pharma
Law

Be Bio rais­es $82M to fund work on B cell ther­a­py in he­mo­phil­ia B

7 months ago
Financing
Startups

Am­gen preps to launch Eylea biosim­i­lar years ear­ly af­ter Re­gen­eron los­es ap­peal

7 months ago
Pharma
Law

Star­board­'s Ken­vue com­plaints are much dif­fer­ent than those aimed at Pfiz­er

7 months ago
Pharma

Lawyers pre­dict Biose­cure pas­sage in lame duck ses­sion, but Sen­ate may de­cide key de­tails

7 months ago
China
Pharma

ICER slight­ly soft­ens its rec­om­men­da­tion on Pfiz­er's AT­TR-CM drug price

7 months ago
Pharma
FDA+

Sam­sung Bio inks largest deal yet worth $1.24B with un­named Asian phar­ma 

7 months ago
Deals
Manufacturing

Ed­i­tas piv­ots away from ex vi­vo sick­le cell ther­a­py in fa­vor of in vi­vo ap­proach

7 months ago
R&D
Cell/Gene Tx

Ot­su­ka’s cy­tokine-tar­get­ing drug for IgAN clears Phase 3 hur­dle

7 months ago
R&D

Macro­Gen­ics sells rights to breast can­cer drug; Rice’s new biotech ac­cel­er­a­tor

7 months ago
News Briefing

Ahead of No­vo’s Ca­griSe­ma read­out, Lil­ly re­turns to a promis­ing new class of obe­si­ty drugs

7 months ago
R&D

'It’s not right.' Califf slams phar­ma over weight loss drug prices

7 months ago
Health Tech

Up­dat­ed: Pfiz­er's ac­tivist says board must 'hold man­age­ment ac­count­able' for R&D short­com­ings

7 months ago
Pharma

Ex­perts de­bate the way AI can trans­form men­tal health­care

7 months ago
Health Tech

For­mer Ama­zon leader is bet­ting the fu­ture of health­care will blend in-per­son and on­line care

7 months ago
Health Tech

FDA hits Ca­mu­rus with CRL for acromegaly ther­a­py over man­u­fac­tur­ing is­sues 

7 months ago
FDA+
Manufacturing
First page Previous page 87888990919293 Next page Last page
A service from the Financial Times